Clinical and laboratory diagnosis of rare coagulation disorders (RCDs)
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 196, 603-608
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 80 references indexed in Scilit:
- Congenital Factor XI Deficiency: An UpdateSeminars in Thrombosis and Hemostasis, 2013
- Factor XIII Deficiency: An UpdateSeminars in Thrombosis and Hemostasis, 2013
- Combined Deficiency of Coagulation Factors V and VIII: An UpdateSeminars in Thrombosis and Hemostasis, 2013
- Congenital Fibrinogen Disorders: An UpdateSeminars in Thrombosis and Hemostasis, 2013
- Congenital Prothrombin Deficiency: An UpdateSeminars in Thrombosis and Hemostasis, 2013
- Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patientsJournal of Thrombosis and Haemostasis, 2012
- Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding DisordersJournal of Thrombosis and Haemostasis, 2012
- Targeted next-generation sequencing for routine clinical screening of mutationsGenome Medicine, 2011
- Bleeding disorders in the tribe: result of consanguineous in breedingOrphanet Journal of Rare Diseases, 2010
- Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complexNature Genetics, 2003